Neurobehavioral Disorders

Latest News

FDA Committees Vote on Novel Therapy for Schizophrenia, Bipolar I Disorder

ALKS 3831 is composed of samidorphan, a mu-opioid receptor antagonist, which is co-formulated with the established antipsychotic agent, olanzapine, in a single bilayer tablet.

Deficits of Short-Term Memory Among Individuals With First-Episode Schizophrenia During Visual Tasks

This study investigates whether contralateral delay activity occurs early in schizophrenia, possibly indicating that visual short-term memory deficits are a core feature of the disorder.

Vascular Depression Symptoms Successfully Ameliorated With Transcranial Direct Current Stimulation

Researchers performed a double-blind randomized study to investigate the efficacy of tDCS as an augmentation strategy to sertraline in the treatment of vascular depression.

OCD Patients With Increased Brain Activity May Respond Better to CBT

This study examines whether pretreatment brain activation during cognitive control and reward processing is associated with treatment response to CBT in patients with OCD.

Gamma Transcranial Alternating Current Stimulation and Mood, Cognition in Major Depressive Disorder

Patients received 40 Hz gamma tACS to provide data on the use of varying stimulation periods.

Cognition Kit DSST App Validated for Measuring Major Depressive Disorder

Researchers conducted a study to evaluate the validity of, and satisfaction with, the Cognition KIT DSST mobile app in patients with major depressive disorder.

Pimavanserin Effective for Depression in Parkinson Disease, Major Depressive Disorder

Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.

Individuals With the Greatest Risk for Schizophrenia Incur Declining Health After Stressful Life Events

Untreated stress amongst healthcare professionals can lead to a multitude of issues while prolonged stress can contribute to burnout. In order to ensure the safety of both clinicians and patients, effective and feasible interventions are needed for individuals and organizations.

People With Depression at Increased Risk of Cannabis Use

The use of cannabis in the past month among US adults with depression increased from 2005 to 2016.

Genomic Data May Unlock Clues to Prevent Depression

Using phenotypic and genomic data from more than 100,000 participants, researchers systematically screened and validated a wide range of potential modifiable factors for depression.